Navigation Links
ViroPharma Incorporated Reports First Quarter 2008 Financial Results
Date:4/30/2008

EXTON, Pa., April 30 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) reported today its financial results for the first quarter ended March 31, 2008.

Key events since December 31, 2007 include:

Development:

-- Notified sites participating in Phase 3 study of Camvia(TM) (maribavir)

in stem cell transplant patients that enrollment will be complete by

the end of May 2008;

-- Patient enrollment continued in Phase 3 study of maribavir in solid

organ transplant patients;

-- Prelaunch activities for maribavir accelerated in preparation for

planned 2009 initial NDA and MAA filing for maribavir in stem cell

transplant patients;

-- Announced in April that we have discontinued the development of HCV-796

due to the previously announced safety issue that emerged in the

ongoing Phase 2 trial in patients with hepatitis C; and

-- Efforts continued to optimize manufacturing and scale up for non-

toxigenic C. difficile (NTCD) program;

Operational:

-- Vincent J. Milano succeeded Michel de Rosen as president and chief

executive officer;

-- Daniel B. Soland appointed chief operating officer;

-- Net sales of Vancocin(R) achieved $51 million;

-- Vancocin direct sales efforts commenced; and

-- Research and development expenses increased by 171 percent over the

first quarter of 2007, primarily driven by investments in maribavir,

NTCD and increased personnel to support clinical development and

regulatory requirements;

Financial Results:

-- Operating income was $20 million;

-- Increased working capital by $25 million to $619 million;<
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. ViroPharma to Present at the Maxim Group First Annual Growth Conference
2. ViroPharma to Present at the UBS Global Life Sciences Conference
3. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
4. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
5. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
6. ViroPharma Augments Senior Management
7. ViroPharma Provides Update on Vancocin(R)
8. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
9. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
10. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
11. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
(Date:12/25/2014)... Recently, BellasDress has launched its ... dresses. BellasDress has chosen their best-selling lace wedding dresses, ... the holiday season. , Now, BellasDress.com features popular ... here at discount prices. The business hopes everyone can ... , “All our elegant products are made ...
(Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping tips ... the models at LunaDress.co.uk come with big discounts, up to 80 ... can turn out to be a most exciting memory and can ... bring surprise to a wedding. On the updated fashion blog, ladies ... for a big day . , Going out with friends to ...
(Date:12/25/2014)... The risk of burns from fires and cooking accidents ... extra cautious, an expert says. "Between Thanksgiving and ... patients coming in with burns," said Dr. Steven Sandoval, ... Center of Stony Brook University Hospital in New York. ... if not careful, could quickly turn tragic," Sandoval said ...
Breaking Medicine News(10 mins):Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2
... Change Student Behavior, BOCA RATON, Fla., Oct. 25 ... sanitizer to help,prevent the spread of germs including the ... hand-to-hand contact, has resulted in the death,of at least ... ill,across the country. The Centers for Disease Control recently ...
... by researchers at the Yale Stem Cell Center for ... class of tiny RNAs, play an important role in ... Nature. , Haifan Lin, director of the stem cell ... of Medicine, heads the laboratory that originally identified piRNAs. ...
... will join more than 100 leading public figures, philanthropists ... New York on 29 October to mark the launch ... US based National Foundation for Cancer Research (NFCR). Through ... Fund at NFCR, Americans can support the IAEA and ...
... Oct. 25 Losing the ability to see, ... steadfast person. Despite,horrific obstacles like these, some plastic ... to inspire and help others in need.,A.J. Reed ... will,be honored with the Patients of Courage: Triumph ...
... MESA, Calif., Oct. 25 CNS Response,Inc. (OTC ... conducted a,quality assurance analysis of its current multi-center ... Based on the evaluation, CNS Response is amending ... issues related to functionality and,operability. Changes to ...
... Net Loss Narrows on Growth of Services Revenues, Higher ... Months; Outlook Improves for 2007 Net Results, POWAY, ... a leading provider of medical diagnostic imaging systems,and services ... losses for the third quarter and nine months ended,September ...
Cached Medicine News:Health News:SafeHands' School Program to Help Fight Spread of MRSA Staph Virus 2Health News:IAEA and NFCR join forces to fight cancer in developing world 2Health News:Amarillo Native Honored for Courage, Selflessness 2Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 2Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 3Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 4Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 5Health News:CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for 'Treatment-Resistant Depression' Study 6Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 2Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 3Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 4Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 5Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 6Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 7Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 8Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 9
(Date:12/24/2014)... 23, 2014  The American Diabetes Association is ... for people with diabetes and that all people ... of statins, in keeping with recent changes to ... American College of Cardiology (ACC) and American Heart ... most recent changes to the Association,s annual revised ...
(Date:12/24/2014)... and RALEIGH, N.C. , Dec. ... Endo International plc (NASDAQ: ENDP ) (TSX: ... BDSI ) announced today that they have submitted a ... to the U.S. Food and Drug Administration (FDA).  Buprenorphine ... of pain severe enough to require daily, around-the-clock, long-term ...
(Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... May 25 Two late-breaking clinical trials presented ... clinical data supporting Abbott,s market-leading XIENCE V® Everolimus Eluting ... of more than 5,000 real-world, complex patients, XIENCE V ... at one year (0.84 percent per Academic Research Consortium ...
... 24 At a town hall meeting a year ago, President Obama ... by keeping older people out of more expensive institutional care.  "I actually think ... it helps keep people in their homes," the president told his audience in ... , , ...
Cached Medicine Technology:New Data Reinforces Safety Profile of Abbott's Market-Leading XIENCE V(R) Drug Eluting Stent 2New Data Reinforces Safety Profile of Abbott's Market-Leading XIENCE V(R) Drug Eluting Stent 3New Data Reinforces Safety Profile of Abbott's Market-Leading XIENCE V(R) Drug Eluting Stent 4New Data Reinforces Safety Profile of Abbott's Market-Leading XIENCE V(R) Drug Eluting Stent 5Medicare Policies Ignore Aging-at-Home Concept 2Medicare Policies Ignore Aging-at-Home Concept 3Medicare Policies Ignore Aging-at-Home Concept 4Medicare Policies Ignore Aging-at-Home Concept 5
... Clarity Classmate video magnifier (model CLCM) was ... has the need to see objects at a ... The Classmate's rotating camera design allows viewing at ... easy to switch between near and distant viewing. ...
... portability together in one product. Flipperport consists ... color camera that captures the image, and ... the magnified image. This self contained, battery-operated ... and comfort. FlipperPort can easily connect with ...
... vision to see objects at a distance, ... between. This battery operated system can be ... used as a desktop video magnifier when ... easy to use and requires no special ...
... incubators designed to provide the ... required for the most demanding ... controlled incubators feature push-button temperature ... display, and built-in over-temperature protection. ...
Medicine Products: